AU563762B2 - S-adenosyl-l-methionine salts preparation - Google Patents

S-adenosyl-l-methionine salts preparation

Info

Publication number
AU563762B2
AU563762B2 AU32326/84A AU3232684A AU563762B2 AU 563762 B2 AU563762 B2 AU 563762B2 AU 32326/84 A AU32326/84 A AU 32326/84A AU 3232684 A AU3232684 A AU 3232684A AU 563762 B2 AU563762 B2 AU 563762B2
Authority
AU
Australia
Prior art keywords
therapeutic compositions
same
excipient
salts
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU32326/84A
Other languages
English (en)
Other versions
AU3232684A (en
Inventor
Pier Luigi Aspesi
Federico Gennari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioresearch SRL
Original Assignee
Bioresearch SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch SRL filed Critical Bioresearch SRL
Publication of AU3232684A publication Critical patent/AU3232684A/en
Application granted granted Critical
Publication of AU563762B2 publication Critical patent/AU563762B2/en
Assigned to BIORESEARCH S.P.A. reassignment BIORESEARCH S.P.A. Alteration of Name(s) in Register under S187 Assignors: BIORESEARCH S.P.A.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AU32326/84A 1983-08-24 1984-08-23 S-adenosyl-l-methionine salts preparation Ceased AU563762B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22621/83A IT1169772B (it) 1983-08-24 1983-08-24 Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina
IT22621/83 1983-08-24

Publications (2)

Publication Number Publication Date
AU3232684A AU3232684A (en) 1985-02-28
AU563762B2 true AU563762B2 (en) 1987-07-23

Family

ID=11198524

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32326/84A Ceased AU563762B2 (en) 1983-08-24 1984-08-23 S-adenosyl-l-methionine salts preparation

Country Status (7)

Country Link
EP (1) EP0136464B1 (enExample)
JP (1) JPS6072815A (enExample)
AT (1) ATE38151T1 (enExample)
AU (1) AU563762B2 (enExample)
CA (1) CA1224418A (enExample)
DE (1) DE3474774D1 (enExample)
IT (1) IT1169772B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3678641D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
EP0212746B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
EP0212747B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release and immediate release
WO1988002629A1 (en) * 1986-10-16 1988-04-21 American Health Products Corporation 2',3'-didesoxyadenosine composition
GB8900812D0 (en) * 1989-01-14 1989-03-08 Univ Manchester Pharmaceutical method and compositions
IT1229479B (it) * 1989-03-13 1991-09-03 Bioresearch Spa Impiego di 5' deossi 5' metiltioadenosina, di s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a favorire la crescita dei capelli in soggetti affetti da calvizie e composizioni farmaceutiche relative.
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
WO2002049637A1 (en) * 2000-12-18 2002-06-27 Orchid Chemicals And Pharmaceuticals Limited A novel soft-gelatin capsule comprising s-adenosylmethionine and a method for producing the same
DE60102938T2 (de) * 2001-12-12 2005-03-31 Chemistry & Health International B.V. Lagerstabile Granulate, die S-Adenosylmethionin enthalten, und Verfahren zu ihrer Herstellung
CA2677053C (en) * 2007-01-31 2016-03-15 Methylation Sciences International Srl Extended release pharmaceutical formulations of s-adenosylmethionine
EP2193787A1 (en) 2008-12-02 2010-06-09 Giorgio Stramentinoli Formulations for systemic buccal delivery comprising s-adenosylmethionine, their preparation and use
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EA015508B1 (ru) * 2011-03-03 2011-08-30 Екофарм Патент Менеджмент Аг Фармацевтическая композиция, стимулирующая биосинтез s-аденозилметионина, и пероральное лекарственное средство
KR101748053B1 (ko) 2012-10-17 2017-06-15 메틸레이션 사이언시즈 인터내셔널 에스알엘 S-아데노실메티오닌 및 갈산 에스테르가 포함된 조성물
EP4712796A2 (en) 2023-05-15 2026-03-25 Bonafide Health, LLC Sleep-improving compositions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
JPS5347536A (en) * 1976-10-12 1978-04-28 Abbott Lab Pharmaceutical composition for treatment of fertile skin disease
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo

Also Published As

Publication number Publication date
EP0136464A3 (en) 1985-07-03
IT8322621A0 (it) 1983-08-24
EP0136464A2 (en) 1985-04-10
JPH0531524B2 (enExample) 1993-05-12
AU3232684A (en) 1985-02-28
IT1169772B (it) 1987-06-03
CA1224418A (en) 1987-07-21
JPS6072815A (ja) 1985-04-24
DE3474774D1 (en) 1988-12-01
EP0136464B1 (en) 1988-10-26
ATE38151T1 (de) 1988-11-15

Similar Documents

Publication Publication Date Title
AU623245B2 (en) Pharmaceutical compositions
AU3232684A (en) S-adenosyl-l-methionine salts preparation
TW234691B (enExample)
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
ES8307210A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1, omega-difenil-aza-alcano.
AU557980B2 (en) Perfluorohydrocarbons as vehicles for drugs
GR3023776T3 (en) Heterocyclic compounds
DE3267295D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
IL87778A0 (en) Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
AU7071487A (en) Chlorpheniramine therapy
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
EP0351876A3 (en) Composition for potentiating vaccination effect
NO164972C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner.
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
FI883730A7 (fi) Eetterit ja tioeetterit, joilla on terapeuttinen vaikutus, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
SE8107833L (sv) Substituerade tetrahydro-1,2,4-oxadiazin-5-on-derivat med kramplosande verkan, sett for deras framstellning och farmaceutiska beredningar innehallandedem
IT1166217B (it) Composizione farmaceutica per la terapia delle sterilita' maschile
IT8421648A1 (it) Nuove difluoroepossidoeritromicine, il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i nuovi prodotti
DE3573724D1 (en) Use of 1,8,9-triacetoxy-anthracene as the active ingredient in the preparation of an antitumoral pharmaceutical compound
IT8025473A0 (it) Derivati piridossinici ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8520150A0 (it) Nuovi derivati ad attivita'terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.